Abstract:BackgroundInfection of SARS-CoV-2 may cause acute respiratory syndrome. It has been reported that SARS-CoV-2 nucleocapsid protein (N-protein) presents early in body fluids during infection. The direct involvement of N-protein in lung injury is poorly understood. MethodsRecombinant N-protein was pretreated with polymyxin B, a lipopolysaccharide (LPS)-neutralizing agent. C57BL/6, C3H/HeJ (resistant to LPS), and C3H/HeN (control for C3H/HeJ) mice were exposed to N-protein via intratracheal administration to examine acute lung injury. In vitro, bone marrow-derived macrophages (BMDMs) were cultured with N-protein to study phosphorylation of nuclear factor kappa B (NF-kappa B) p65, macrophage polarization, and expression of proinflammatory cytokines. ResultsN-protein produced acute lung injury in C57BL/6 mice, with elevated protein permeability, total cell count, neutrophil infiltration, and proinflammatory cytokines in the bronchioalveolar lavage. N-protein also induced lung injury in both C3H/HeJ and C3H/HeN mice, indicating that the effect could not be attributed to the LPS contamination. N-protein triggered phosphorylation of NF-kappa B p65 in vitro, which was abolished by both N-protein denaturation and treatment with an antibody for N-protein, demonstrating that the effect is N-protein specific. In addition, N-protein promoted M1 macrophage polarization and the expression of proinflammatory cytokines, which was also blocked by N-protein denaturation and antibody for N-protein. Furthermore, N-protein induced NF-kappa B p65 phosphorylation in the lung, while pyrrolidine dithiocarbamate, an NF-kappa B inhibitor, alleviated the effect of N-protein on acute lung injury. ConclusionsSARS-CoV-2 N-protein itself is toxic and induces acute lung injury in mice. Both N-protein and NF-kappa B pathway may be therapeutic targets for treating multi-organ injuries in Coronavirus disease 2019 (COVID-19).

RNA-induced Liquid Phase Separation of SARS-CoV-2 Nucleocapsid Protein Facilitates NF-κB Hyper-Activation and Inflammation.

Overly Exuberant Innate Immune Response to SARS-CoV-2 Infection

Signaling mechanisms of SARS-CoV-2 Nucleocapsid protein in viral infection, cell death and inflammation

SARS-CoV-2 Nucleocapsid Protein Impairs SG Assembly by Partitioning into G3BP Condensate

SARS-CoV-2 spike protein induces inflammation via TLR2-dependent activation of the NF-κB pathway

SARS-CoV-2 N protein promotes NLRP3 inflammasome activation to induce hyperinflammation

ACE2-dependent and -Independent SARS-CoV-2 Entries Dictate Viral Replication and Inflammatory Response During Infection

SARS-CoV-2 N Protein Induces Acute Lung Injury in Mice <i>via</i> NF-B Activation

Targeting liquid–liquid phase separation of SARS-CoV-2 nucleocapsid protein promotes innate antiviral immunity by elevating MAVS activity

SARS-CoV-2 Nucleocapsid Protein Triggers Hyperinflammation Via Protein-Protein Interaction-Mediated Intracellular Cl − Accumulation in Respiratory Epithelium

Understanding the Phase Separation Characteristics of Nucleocapsid Protein Provides a New Therapeutic Opportunity Against SARS-CoV-2

SARS-CoV-2 N Protein Triggers Acute Lung Injury Via Modulating Macrophage Activation and Infiltration in in Vitro and in Vivo

SARS-CoV-2 Z-RNA activates the ZBP1-RIPK3 pathway to promote virus-induced inflammatory responses

SARS-CoV-2 RNA stabilizes host mRNAs to elicit immunopathogenesis

SARS-CoV-2 nucleocapsid protein dually regulates innate immune responses

A dual-role of SARS-CoV-2 nucleocapsid protein in regulating innate immune response

SARS-CoV-2 Nsp5 Activates NF-κB Pathway by Upregulating SUMOylation of MAVS

SARS-CoV-2 infection induces a pro-inflammatory cytokine response through cGAS-STING and NF-κB

Ubiquitination of SARS-CoV-2 NSP6 and ORF7a Facilitates NF-κB Activation

NLRP12 Senses the SARS-CoV-2 Membrane Protein and Promotes an Inflammatory Response.

Linear ubiquitination mediates coronavirus NSP14-induced NF-κB activation